Chiropractors in Whitehall, MT Accepting Medicare
2 Chiropractors found. Showing 1 - 2
 Whitehall Chiropractic Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 511 W Legion Ave, Whitehall, MT 59759 Phone: 406-287-3217 Fax: 406-287-3217 |
 Dr. Katherine Klar Meyer, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 511 W Legion Ave, Whitehall, MT 59759 Phone: 406-287-3217 Fax: 406-287-3217 |
News Archive
Massachusetts' Senate election could shape health reform's endgame
"Democrat Martha Coakley's struggle to stave off a potentially devastating defeat in Tuesday's special Senate election in Massachusetts marks a critical turning point in the year-long debate about health-care reform."
RBCC's new agreement with n3D could help develop stem-cell therapies
As global demand for innovative new stem-cell therapies grows by the day, Rainbow BioSciences' new agreement with n3D Biosciences could help to bring these therapies to market faster than ever before.
U.S. PTO grants reissue patent concerning OSI Pharmaceuticals' Tarceva
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
Gleevec reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors
Data published online and in an upcoming print issue of The Lancet show that Gleevec (imatinib mesylate) tablets, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.
Blocking immune receptor molecule improves response to HIV-like virus, prolongs survival in monkeys
By blocking PD-1 (programmed death-1), an immune receptor molecule known to inhibit the immune response to chronic viral infections, scientists have safely and significantly reduced the plasma viral load and also prolonged survival of rhesus macaque monkeys severely infected with simian immunodeficiency virus (SIV), the nonhuman primate version of human immunodeficiency virus (HIV).
› Verified 1 days ago